<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21494635</article-id><article-id pub-id-type="pmc">3073001</article-id><article-id pub-id-type="publisher-id">PONE-D-10-06257</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0018737</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry</subject><subj-group><subject>Environmental Chemistry</subject><subj-group><subject>Atmospheric Chemistry</subject><subj-group><subject>Ozone</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Anatomy and Physiology</subject><subj-group><subject>Cardiovascular System</subject><subj-group><subject>Circulatory Physiology</subject></subj-group></subj-group><subj-group><subject>Neurological System</subject><subj-group><subject>Nervous System Physiology</subject></subj-group></subj-group><subj-group><subject>Respiratory System</subject><subj-group><subject>Respiratory Physiology</subject></subj-group></subj-group><subj-group><subject>Integrative Physiology</subject></subj-group></subj-group><subj-group><subject>Cardiovascular</subject><subj-group><subject>Hemodynamics</subject></subj-group></subj-group><subj-group><subject>Public Health</subject><subj-group><subject>Environmental Health</subject></subj-group></subj-group><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Infections</subject><subj-group><subject>Upper Respiratory Tract Infections</subject></subj-group></subj-group><subj-group><subject>Chronic Obstructive Pulmonary Diseases</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Effect of Acute Ozone Induced Airway Inflammation on Human
Sympathetic Nerve Traffic: A Randomized, Placebo Controlled, Crossover
Study</article-title><alt-title alt-title-type="running-head">Airway Inflammation and Sympathetic Nerve
Traffic</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tank</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>&#x0002a;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Biller</surname><given-names>Heike</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Heusser</surname><given-names>Karsten</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Holz</surname><given-names>Olaf</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Diedrich</surname><given-names>Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Framke</surname><given-names>Theodor</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Koch</surname><given-names>Armin</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Grosshennig</surname><given-names>Anika</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Koch</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Krug</surname><given-names>Norbert</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jordan</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hohlfeld</surname><given-names>Jens M.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Institute of Clinical Pharmacology, Hannover
Medical School, Hannover, Germany</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Fraunhofer Institute for Toxicology and
Experimental Medicine (ITEM), Hannover, Germany</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Division of Clinical Pharmacology, Department
of Medicine, Autonomic Dysfunction Center, Vanderbilt University School of
Medicine, Nashville, Tennessee, United States of America</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Department of Biomedical Engineering,
Vanderbilt University School of Engineering, Nashville, Tennessee, United States
of America</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Institute for Biometry, Hannover Medical
School, Hannover, Germany</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Bochud</surname><given-names>Murielle</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University Institute of Social and Preventive Medicine,
Switzerland</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>tank.jens@mh-hannover.de</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JMH JJ NK WK KH JT. Performed the
experiments: JT HB KH OH. Analyzed the data: JT AD TF AK AG HB. Contributed
reagents/materials/analysis tools: AD. Wrote the paper: JT JJ JH OH.</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>8</day><month>4</month><year>2011</year></pub-date><volume>6</volume><issue>4</issue><elocation-id>e18737</elocation-id><history><date date-type="received"><day>8</day><month>12</month><year>2010</year></date><date date-type="accepted"><day>12</day><month>3</month><year>2011</year></date></history><permissions><copyright-statement>Tank et al.</copyright-statement><copyright-year>2011</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Ozone concentrations in ambient air are related to cardiopulmonary
perturbations in the aging population. Increased central sympathetic nerve
activity induced by local airway inflammation may be one possible
mechanism.</p></sec><sec><title>Methodology/Principal Findings</title><p>To elucidate this issue further, we performed a randomized, double-blind,
cross-over study, including 14 healthy subjects (3 females, age 22&#x02013;47
years), who underwent a 3 h exposure with intermittent exercise to either
ozone (250 ppb) or clean air. Induced sputum was collected 3 h after
exposure. Nineteen to 22 hours after exposure, we recorded ECG, finger blood
pressure, brachial blood pressure, respiration, cardiac output, and muscle
sympathetic nerve activity (MSNA) at rest, during deep breathing,
maximum-inspiratory breath hold, and a Valsalva maneuver. While the ozone
exposure induced the expected airway inflammation, as indicated by a
significant increase in sputum neutrophils, we did not detect a significant
estimated treatment effect adjusted for period on cardiovascular
measurements. Resting heart rate (clean air: 59&#x000b1;2, ozone 60&#x000b1;2
bpm), blood pressure (clean air: 121&#x000b1;3/71&#x000b1;2 mmHg; ozone:
121&#x000b1;2/71&#x000b1;2 mmHg), cardiac output (clean air: 7.42&#x000b1;0.29
mmHg; ozone: 7.98&#x000b1;0.60 l/min), and plasma norepinephrine levels
(clean air: 213&#x000b1;21 pg/ml; ozone: 202&#x000b1;16 pg/ml), were similar
on both study days. No difference of resting MSNA was observed between ozone
and air exposure (air: 23&#x000b1;2, ozone: 23&#x000b1;2 bursts/min). Maximum
MSNA obtained at the end of apnea (air: 44&#x000b1;4, ozone: 48&#x000b1;4
bursts/min) and during the phase II of the Valsalva maneuver (air:
64&#x000b1;5, ozone: 57&#x000b1;6 bursts/min) was similar.</p></sec><sec><title>Conclusions/Significance</title><p>Our study suggests that acute ozone-induced airway inflammation does not
increase resting sympathetic nerve traffic in healthy subjects, an
observation that is relevant for environmental health. However, we can not
exclude that chronic airway inflammation may contribute to sympathetic
activation.</p></sec></abstract><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Based on large epidemiological studies, the World Health Organization estimated that
air pollution is the 13<sup>th</sup> leading cause of mortality worldwide.<xref rid="pone.0018737-World1" ref-type="bibr">[1]</xref> A large
proportion of the excess mortality can be attributed to cardiovascular deaths.<xref rid="pone.0018737-Pope1" ref-type="bibr">[2]</xref> Long term exposure
to fine particles and to ozone were associated with an increased cardiopulmonary
mortality.<xref rid="pone.0018737-Jerrett1" ref-type="bibr">[3]</xref>
Short term exposure to air pollutants is sufficient to elicit changes in
cardiovascular and pulmonary function in healthy subjects<xref rid="pone.0018737-Kim1" ref-type="bibr">[4]</xref> and in patients<xref rid="pone.0018737-Liu1" ref-type="bibr">[5]</xref>. The rapid onset
implicates a neural mechanism. Indeed, autonomic nervous system imbalance with
raised sympathetic and attenuated parasympathetic activity may contribute to
cardiovascular morbidity and mortality in this setting.<xref rid="pone.0018737-Thayer1" ref-type="bibr">[6]</xref> Increased ozone and fine
particle exposure were associated with attenuated heart rate variability (HRV) and
excessive oxidative stress and inflammatory biomarkers in venous blood samples.<xref rid="pone.0018737-Chuang1" ref-type="bibr">[7]</xref>, <xref rid="pone.0018737-Park1" ref-type="bibr">[8]</xref>, <xref rid="pone.0018737-Gold1" ref-type="bibr">[9]</xref> Ozone exposure
reduced HRV in asthma patients <xref rid="pone.0018737-Power1" ref-type="bibr">[10]</xref> but not in otherwise healthy older subjects.<xref rid="pone.0018737-LuttmannGibson1" ref-type="bibr">[11]</xref> Field
studies cannot dissect the individual contribution of pollutants on cardiovascular
control. The mechanisms through which ozone and fine particle influence autonomic
function may differ.<xref rid="pone.0018737-Fakhri1" ref-type="bibr">[12]</xref>, <xref rid="pone.0018737-Power1" ref-type="bibr">[10]</xref>, <xref rid="pone.0018737-Gold1" ref-type="bibr">[9]</xref> Moreover, all previous studies relied on indirect
methodologies, such as HRV analysis, to assess autonomic cardiovascular regulation.
None employed direct measurements of muscle sympathetic nerve activity (MSNA) or
detailed plasma catecholamine analysis. In animals, experimental inflammation in the
kidney<xref rid="pone.0018737-Ye1" ref-type="bibr">[13]</xref> or in
gastrointestinal organs<xref rid="pone.0018737-Ordway1" ref-type="bibr">[14]</xref> increases central sympathetic activity through afferent
neural pathways. Ozone induced airway inflammation <xref rid="pone.0018737-Holz1" ref-type="bibr">[15]</xref> could elicit a similar response.
A similar mechanism could also contribute to sympathetic activation in patients with
chronic obstructive pulmonary disease<xref rid="pone.0018737-Bernardi1" ref-type="bibr">[16]</xref> or asthma.<xref rid="pone.0018737-Kumar1" ref-type="bibr">[17]</xref> We challenged
healthy volunteers with ozone in a double blind, randomized, and cross-over fashion
to test the hypothesis that neutrophilic airway inflammation induced by acute ozone
exposure is accompanied by increased muscle sympathetic nerve activity.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Participants</title><p>Healthy ozone responsive women and men aged 22 to 47 years with forced expiratory
volume in the first second (FEV<sub>1</sub>) &#x0003e;80&#x00025; were eligible for
our study. Subjects had to respond to ozone during a screening challenge with
250 ppb ozone over three hours. We defined a response as &#x02265;10&#x00025; increase
in sputum neutrophils 6 hours after the start of ozone exposure. Subjects with
respiratory tract infection in four weeks before screening or a positive skin
prick test to common aeroallergens were excluded. Subjects regularly taking
prescription or over the counter medication except acetaminophen for pain
relief, oral contraceptives, hormonal replacement therapy, or vitamin
supplements were also excluded.</p></sec><sec id="s2b"><title>Ethics statement</title><p>The ethics committee of the Hannover Medical School, Carl Neuberg Str. 1, 30625
Hannover, Germany, approved the study and all patients gave written informed
consent.</p></sec><sec id="s2c"><title>Protocol</title><p>We exposed healthy ozone responsive subjects in a randomized, double-blinded,
cross-over fashion for 3 hours to ozone (250 ppb) or clean air. In the
Fraunhofer ozone exposure chamber (2.7&#x000d7;2.3&#x000d7;2.5 m<sup>3</sup>), air
temperature and relative humidity were kept in a range of 20&#x02013;25&#x000b0;C and
40&#x02013;60&#x00025;, respectively. A high purity ozone mass flux was generated
using commercial generator (COM_ADM, ANSEROS GmbH, T&#x000fc;bingen, Germany).
Ozone concentration in the chamber was continuously monitored by two independent
analyzers (Ozomat MP, ANSEROS, T&#x000fc;bingen, and 400A, MLU-Messtechnik f&#x000fc;r
Luft und Umwelt GmbH, Essen). During exposure, subjects conducted intermittent
bicycle ergometer training for 15 minutes at intensities increasing ventilation
to 20 l/min/m<sup>2</sup> alternating with 15 minutes rest. Sessions were
conducted at least 2 weeks apart.</p><p>We obtained induced sputum 6 hours after the start of challenge. Subjects inhaled
ultrasonically nebulized pyrogen-free hypertonic saline through a mouthpiece
while wearing a nose clip. After 5 minutes inhalation, we asked subjects to
rinse the mouth and blow the nose to minimize sputum contamination. Then,
subjects expectorated into a sterile container. Saline concentration was
increased stepwise from 3&#x00025; to 4&#x00025; and 5&#x00025; with expectoration
after each step. Sputum was immediately processed. In short, sputum plugs were
selected from the whole expectorate (including saliva), and transferred to a
pre-weighted cup to determine its weight. To homogenize the sputum, 4 volumes of
freshly prepared 0.1&#x00025; sputolysin (dithiothrietol) was added and incubated
for 15 min on a bench rocker. The dispersed sputum was filtered through a 70
&#x000b5;m cell strainer and the cell number was counted by hemacytometer. The
differential cell count was assessed on cytospin slides by counting at least 400
non-squamous cells.<xref rid="pone.0018737-Holz2" ref-type="bibr">[18]</xref>, <xref rid="pone.0018737-Holz3" ref-type="bibr">[19]</xref>
</p><p>Blood samples were obtained from a cubital vein before as well as 5, 7, and 24
hours after start of exposure challenge. Spirometry was performed according to
ATS standards before as well as 3, 6, and 24 hours after start of challenge.
Cardiovascular and microneurographic measurements were obtained approximately 19
to 22 hours after end of exposure.</p></sec><sec id="s2d"><title>Cardiovascular and sympathetic measurements</title><p>We conducted our measurements after an overnight fast in the morning hours.
During testing, subjects remained in the supine position. Electrocardiogram,
beat-by-beat blood pressure (Finapres, Ohmeda, Englewood, CA, U.S.A.), and
brachial blood pressure (Dinamap, Critikon, Tampa, FL, U.S.A.) were determined.
We inserted one antecubital venous catheter for blood sampling. Muscle
sympathetic nerve activity was recorded from the right peroneal nerve (Nerve
Traffic Analyzer 662C-3, Biomedical Engineering Department, University of Iowa,
Iowa City, IA, USA) as described previously.<xref rid="pone.0018737-Tank1" ref-type="bibr">[20]</xref> Briefly, a tungsten electrode
with uninsulated tip (diameter 1&#x02013;5 &#x000b5;m, shaft diameter 200 &#x000b5;m,
2 Mega Ohm, Frederick Haer and Co, Bowdoinham, MA) was inserted into the muscle
nerve fascicles of the peroneal nerve at the fibular head. The raw nerve signal
was band-pass filtered (700&#x02013;2000 Hz), amplified (100&#x000d7;999.9),
rectified and integrated (time constant of 0&#x022c5;1 s) to obtain mean voltage
neurograms (IMSNA) using the nerve traffic analysis system (662C-3, University
of Iowa). Satisfactory recordings of MSNA were defined by (1) heart pulse
synchronicity; (2) facilitation during Valsalva straining and suppression during
the hypertensive overshoot phase after release; (3) increases in response to
breath-holding; and (4) no change during tactile or auditory stimulation.</p><p>MSNA bursts were identified by an automated detection algorithm with artifact
elimination, dynamic noise level detection, and signal-to-noise estimation in
the integrated signal. Bursts were accepted if the signal-to-noise ratio was
greater than 2:1 and synchronization to a previous cardiac event was found in an
interval between 1.2&#x02013;1.6 seconds. All detections were visually
verified.</p><p>After a resting period of at least 30 minutes, we obtained baseline recordings
over 15 minutes. Then, we obtained blood samples for plasma catecholamine
determination with high pressure liquid chromatography. Cardiac output
measurements were obtained using an inert gas rebreathing method (Innocor,
Innovision A/S, Odense, Denmark).</p><p>After baseline measurements had been obtained, we determined cardiovascular
responses to fixed breathing at a rate of six breaths per minute in order to
reach the highest heart rate variability values in individual subjects.<xref rid="pone.0018737-Hirsch1" ref-type="bibr">[21]</xref> Then,
subjects were asked to perform a Valsalva maneuver, by exhaling into a
mouthpiece fixed to a mercury manometer with a pressure of 40 mmHg column for 15
sec. Finally, subjects conducted a maximum voluntary inspiratory breath hold
maneuver.</p><p>Signals were digitized at a sampling rate of 500 Hz and 16 bit resolution using
hardware based intelligent oversampling method (DI720USB, DATAQ Instruments,
Akron, OH), and then processed with user software written in PV-Wave (Visual
Numerics Inc., Houston, TX). We determined the following MSNA parameters from
the integrated nerve signal: the burst frequency, i.e. the number of MSNA bursts
per minute (bursts/min), the burst incidence, i.e. the number of bursts per 100
heart beats (bursts/100 heart beats), as well as the total activity, i.e. the
area under the bursts per minute as arbitrary units per minute (au/min). <xref rid="pone.0018737-Tank1" ref-type="bibr">[20]</xref>
</p><p>Beat-to-beat values of detected R&#x02013;R intervals and BP values were
interpolated, low-pass filtered (cutoff 0.5 Hz) and re-sampled at 4 Hz. Data
segments of 300 s were used for spectral analysis. Linear trends were removed
and power spectral density was estimated with the FFT-based Welch algorithm
using segments of 256 data points with 50&#x00025; overlapping and Hanning
window. The power in the frequency range of low frequencies (LF: 0.04 to 0.15
Hz) and high frequencies (HF: 0.15 to 0.40 Hz) was calculated following Task
Force recommendations.<xref rid="pone.0018737-Heart1" ref-type="bibr">[22]</xref>
</p><p>Baroreflex gain was defined as the mean magnitude value of the transfer function
between systolic blood pressure and R-R intervals in the low-frequency (BRSLF)
and high-frequency (BRSHF) band with negative phase and squared coherence value
greater than 0.5. We calculated for our settings (300 sec at 4 Hz, 256 data
points segment length, Hanning window) coherence values of 0.33 for p&#x0003c;0.01
and 0.229 for p&#x0003c;0.05. Thus, the coherence limit of 0.5 applied by us and
others is suitable for the calculation of baroreflex sensitivity.<xref rid="pone.0018737-Immink1" ref-type="bibr">[23]</xref> Spontaneous
baroreflex slope was calculated as the slope of the linear regression line
between the systolic BP and the subsequent R-R intervals using sequences defined
as an episode of at least three heart beats with more than 0.5 mm Hg systolic BP
changes and 5 msec R-R interval changes. For sequences with rising (BRSup) and
falling BP (BRSdown) the averaged value of slopes with a correlation coefficient
greater than 0.85 was calculated.</p></sec><sec id="s2e"><title>Statistical analysis</title><p>All data are expressed as mean &#x000b1; SEM. All parameters were evaluated by a
standard cross over analysis with a two-sided t-test adjusting for a potential
period effect. Continuous variables were checked for the normal distribution
assumption using the D'Agostino and Pearson omnibus normality test. In case
of a non Gaussian distribution of the variable the results were confirmed with a
non parametric test (Wilcoxon signed rank test) using GraphPad-Prism 5.</p><p>For description of the adjusted period effect, means, standard deviations,
minimum, maximum and medians for each period and sequence were analyzed.
95&#x00025; confidence intervals and p-values were calculated. R 2.11.0 has been
used for calculations (including packages lattice 0.18&#x02013;8 and reshape
2.11.0). For the power/sample size calculation, R 2.11.0 and nQuery 7 have been
used. A value for p&#x0003c;0.05 was considered significant. Based on the assumption
of a relevant treatment difference of 5 bursts/min a sample size of 11 subjects
was calculated for the parameter burst frequency at baseline to achieve a power
of 80&#x00025; to detect a difference in measurements after ozone or clean air
(two sided t-test, type I error of 5&#x00025;).</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Cohort characteristics and disposition</title><p>We included fifteen healthy, ozone-responsive subjects in our study (12 men, 3
women, age 22 to 47 years (34 &#x0002b;/&#x02212; 10 years), body weight 59 to 104 kg
(80 &#x0002b;/&#x02212; 11 kg). One subjects had to be withdrawn due to an upper
respiratory tract infection. Two successful nerve recordings of comparable
quality could be obtained in 11 subjects. Characteristics of the subjects are
shown in <xref ref-type="table" rid="pone-0018737-t001">table 1</xref>.</p><table-wrap id="pone-0018737-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018737.t001</object-id><label>Table 1</label><caption><title>Characteristics of the study population.</title></caption><alternatives><graphic id="pone-0018737-t001-1" xlink:href="pone.0018737.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sequence 1 (air -&#x0003e; ozone)</td><td align="left" rowspan="1" colspan="1">Sequence 2 (ozone -&#x0003e; air)</td><td align="left" rowspan="1" colspan="1">Total</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">Male (&#x00025;)</td><td align="left" rowspan="1" colspan="1">4 (66.7&#x00025;)</td><td align="left" rowspan="1" colspan="1">7 (87.5&#x00025;)</td><td align="left" rowspan="1" colspan="1">11 (78.6&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1">Age [years]</td><td align="left" rowspan="1" colspan="1">33.2 (&#x000b1;10.34)</td><td align="left" rowspan="1" colspan="1">34.1 (&#x000b1;9.5)</td><td align="left" rowspan="1" colspan="1">33.7 (&#x000b1;9.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight [kg]</td><td align="left" rowspan="1" colspan="1">76.7 (&#x000b1;10.7)</td><td align="left" rowspan="1" colspan="1">83.12 (&#x000b1;11.9)</td><td align="left" rowspan="1" colspan="1">80.4 (&#x000b1;11.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Height [cm]</td><td align="left" rowspan="1" colspan="1">179.8 (&#x000b1;8.4)</td><td align="left" rowspan="1" colspan="1">185.6 (&#x000b1;5.7)</td><td align="left" rowspan="1" colspan="1">183.1 (&#x000b1;7.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI [kg/m<sup>2</sup>]</td><td align="left" rowspan="1" colspan="1">23.6 (&#x000b1;1.8)</td><td align="left" rowspan="1" colspan="1">24.0 (&#x000b1;2.3)</td><td align="left" rowspan="1" colspan="1">23.9 (&#x000b1;2.0)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>Shown are either absolute frequencies and percentages or means and
standard deviations.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Ozone-induced airway inflammation</title><p>The percentage of neutrophils in induced sputum obtained 6 hours after the start
of challenge (n&#x0200a;=&#x0200a;14) was increased after ozone compared to
clean air (estimated treatment effect adjusted for period: 16&#x00025;
(difference of percentages), 95&#x00025; CI: 4.06&#x00025; to 28.22&#x00025;,
p&#x0003c;0.05), indicating the presence of neutrophilic airway inflammation (<xref ref-type="table" rid="pone-0018737-t002">table 2</xref>). FEV<sub>1</sub> at
baseline was 4.4 &#x0002b;/&#x02212; 0.6 L before the clean air exposure and 4.4
&#x0002b;/&#x02212; 0.7 L before the ozone exposure. Forced vital capacity (FVC) at
baseline was 5.5 &#x0002b;/&#x02212; 0.8 L before the clean air exposure and 5.5
&#x0002b;/&#x02212; 0.7 L before the ozone exposure. Immediately after leaving the
challenge chamber, FEV<sub>1</sub> and FVC were significantly decreased
(FEV<sub>1</sub>: estimated treatment effect adjusted for period:
&#x02212;0.37 L, 95&#x00025; CI: &#x02212;0.58 L to &#x02212;0.15 L, p&#x0003c;0.005; FVC:
estimated treatment effect: &#x02212;0.32 L, 95&#x00025; CI: &#x02212;0.48 L to
&#x02212;0.16 L, p&#x0003c;0.005). However, 24 hours after the start of challenge, the
effect of ozone exposure on lung function parameters was no longer observed
(FEV<sub>1</sub>: estimated treatment effect adjusted for period: 0.007 L,
95&#x00025; CI: &#x02212;0.07 L to &#x02212;0.085 L, p&#x0200a;=&#x0200a;0.844;
FVC: estimated treatment effect: 0.042 L, 95&#x00025; CI: &#x02212;0.047 L to
&#x02212;0.131 L, p&#x0200a;=&#x0200a;0.321). Airway inflammation was
paralleled by signs of systemic inflammation. The percentage of neutrophils in
peripheral blood was increased 5 hours after start of ozone challenge compared
with clean air (estimated treatment effect adjusted for period:
&#x0002b;10.24&#x00025; (difference of percentages), 95&#x00025; CI: 5.95&#x00025; to
14.52&#x00025;, p&#x0003c;0.0005). At 24 hours after challenge, all changes in the
peripheral white blood cell count had recovered to baseline (estimated treatment
effect adjusted for period difference of percentages of neutrophils in
peripheral blood: &#x02212;0.964&#x00025;, 95&#x00025; CI: &#x02212;7.993&#x00025; to
6.064&#x00025;, p&#x0003c;0.768).</p><table-wrap id="pone-0018737-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018737.t002</object-id><label>Table 2</label><caption><title>Differential cell count in induced sputum at baseline and the
exposure effect adjusted for period 6 hours after the start of exposure
to ozone compared to clean air.</title></caption><alternatives><graphic id="pone-0018737-t002-2" xlink:href="pone.0018737.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Parameter</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">Treatment effect</td><td align="left" rowspan="1" colspan="1">95&#x00025;CI</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Neutros/g</td><td align="left" rowspan="1" colspan="1">42.2&#x000b1;10.3</td><td align="left" rowspan="1" colspan="1">91.82&#x000b1;39.7</td><td align="left" rowspan="1" colspan="1">5,23</td><td align="left" rowspan="1" colspan="1">178,4</td><td align="left" rowspan="1" colspan="1">0,0394</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutros perc</td><td align="left" rowspan="1" colspan="1">42.4&#x000b1;5.4</td><td align="left" rowspan="1" colspan="1">16.14&#x000b1;5.54</td><td align="left" rowspan="1" colspan="1">4,06</td><td align="left" rowspan="1" colspan="1">28,22</td><td align="left" rowspan="1" colspan="1">0,0131</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cells</td><td align="left" rowspan="1" colspan="1">171.3&#x000b1;46.3</td><td align="left" rowspan="1" colspan="1">98.38&#x000b1;82.5</td><td align="left" rowspan="1" colspan="1">&#x02212;81,4</td><td align="left" rowspan="1" colspan="1">278,2</td><td align="left" rowspan="1" colspan="1">0,2563</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cells/g</td><td align="left" rowspan="1" colspan="1">84.6&#x000b1;11.4</td><td align="left" rowspan="1" colspan="1">92.41&#x000b1;47.7</td><td align="left" rowspan="1" colspan="1">&#x02212;11,4</td><td align="left" rowspan="1" colspan="1">196,3</td><td align="left" rowspan="1" colspan="1">0,0764</td></tr><tr><td align="left" rowspan="1" colspan="1">Macros perc</td><td align="left" rowspan="1" colspan="1">25.0&#x000b1;4.0</td><td align="left" rowspan="1" colspan="1">&#x02212;11&#x000b1;4.61</td><td align="left" rowspan="1" colspan="1">&#x02212;21,1</td><td align="left" rowspan="1" colspan="1">&#x02212;0,95</td><td align="left" rowspan="1" colspan="1">0,0345</td></tr><tr><td align="left" rowspan="1" colspan="1">Eos perc</td><td align="left" rowspan="1" colspan="1">0.02&#x000b1;0.02</td><td align="left" rowspan="1" colspan="1">&#x02212;0.12&#x000b1;0.06</td><td align="left" rowspan="1" colspan="1">&#x02212;0,25</td><td align="left" rowspan="1" colspan="1">0,01</td><td align="left" rowspan="1" colspan="1">0,0693</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphos perc</td><td align="left" rowspan="1" colspan="1">1.04&#x000b1;0.19</td><td align="left" rowspan="1" colspan="1">&#x02212;0.48&#x000b1;0.44</td><td align="left" rowspan="1" colspan="1">&#x02212;0,47</td><td align="left" rowspan="1" colspan="1">1,43</td><td align="left" rowspan="1" colspan="1">0,2935</td></tr><tr><td align="left" rowspan="1" colspan="1">Monos perc</td><td align="left" rowspan="1" colspan="1">0.79&#x000b1;0.18</td><td align="left" rowspan="1" colspan="1">&#x02212;0&#x000b1;0.51</td><td align="left" rowspan="1" colspan="1">&#x02212;1,11</td><td align="left" rowspan="1" colspan="1">1,12</td><td align="left" rowspan="1" colspan="1">0,9946</td></tr><tr><td align="left" rowspan="1" colspan="1">Epis perc</td><td align="left" rowspan="1" colspan="1">30.8&#x000b1;4.6</td><td align="left" rowspan="1" colspan="1">&#x02212;5.5&#x000b1;3.12</td><td align="left" rowspan="1" colspan="1">&#x02212;12,3</td><td align="left" rowspan="1" colspan="1">1,3</td><td align="left" rowspan="1" colspan="1">0,1034</td></tr><tr><td align="left" rowspan="1" colspan="1">Squamous cells</td><td align="left" rowspan="1" colspan="1">26.7&#x000b1;4.0</td><td align="left" rowspan="1" colspan="1">&#x02212;5.52&#x000b1;4.46</td><td align="left" rowspan="1" colspan="1">&#x02212;15,2</td><td align="left" rowspan="1" colspan="1">4,19</td><td align="left" rowspan="1" colspan="1">0,2392</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell viability</td><td align="left" rowspan="1" colspan="1">58.1&#x000b1;5.5</td><td align="left" rowspan="1" colspan="1">&#x02212;5.44&#x000b1;3.73</td><td align="left" rowspan="1" colspan="1">&#x02212;13,6</td><td align="left" rowspan="1" colspan="1">2,7</td><td align="left" rowspan="1" colspan="1">0,1711</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p>Mean &#x000b1; SEM, n&#x0200a;=&#x0200a;14, CI confidence limits,
g&#x0200a;=&#x0200a;gram, perc &#x0200a;=&#x0200a; per
cent, cells/g &#x0200a;=&#x0200a; cells/gram, neutros
&#x0200a;=&#x0200a; neutrophil granulocytes, macros
&#x0200a;=&#x0200a; macrophages, eos &#x0200a;=&#x0200a;
eosinophil granulocytes, lymphos &#x0200a;=&#x0200a;
lymphocytes, epis &#x0200a;=&#x0200a; epithelial cells.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c"><title>Hemodynamics and sympathetic regulation</title><p>Resting HR was 59&#x000b1;2 bpm after exposure to clean air and 60&#x000b1;2 after
ozone exposure. Resting systolic blood pressure (clean air: 121&#x000b1;3 mmHg;
ozone: 121&#x000b1;2 mmHg), diastolic blood pressure (clean air: 71&#x000b1;2
mmHg; ozone: 71&#x000b1;2 mmHg), cardiac output (clean air: 7.42&#x000b1;0.29
mmHg; ozone: 7.98&#x000b1;0.60 l/min), plasma norepinephrine levels (clean air:
213&#x000b1;21 pg/ml; ozone: 202&#x000b1;16 pg/ml), and plasma epinephrine levels
(clean air: 23&#x000b1;3 pg/ml; ozone: 23&#x000b1;3 pg/ml) were similar on both
study days. No significant estimated treatment effect adjusted for period was
detected for HR, BP, CO and plasma catecholamines.</p><p>
<xref ref-type="fig" rid="pone-0018737-g001">Figure 1</xref> illustrates
sympathetic nerve recordings on both study days for two subjects with different
sequence. Muscle sympathetic nerve activity was similar after exposure to ozone
and to clean air. <xref ref-type="fig" rid="pone-0018737-g002">Figure 2</xref>
shows individual values of muscle sympathetic nerve activity measured after
clean air and ozone exposure. <xref ref-type="table" rid="pone-0018737-t003">Table 3</xref> presents the mean values of sympathetic nerve activity as
burst frequency, burst incidence and area under the burst measured on both study
days at rest, during deep breathing, at the end of maximum inspiratory apnea and
during late phase II of the Valsalva maneuver. No significant estimated
treatment effect adjusted for period was detected. MSNA at the end of apnea
quantified as burst area tended to be increased with ozone.</p><fig id="pone-0018737-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018737.g001</object-id><label>Figure 1</label><caption><title>Examples of integrated muscle sympathetic nerve activity recorded at
about 19&#x02013;22 hours after exposure to clean air or to ozone in two
subjects.</title></caption><graphic xlink:href="pone.0018737.g001"/></fig><fig id="pone-0018737-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018737.g002</object-id><label>Figure 2</label><caption><title>Individual values of muscle sympathetic nerve activity (burst
frequency in bursts/min) measured after clean air and ozone exposure at
rest (top), at the end of maximum inspiratory apnea (middle) and during
late phase II of the Valsalva maneuver (bottom) for subjects exposed
first to clean air (empty circles, n&#x0200a;=&#x0200a;4) and for
subjects exposed first to ozone (filled circles,
n&#x0200a;=&#x0200a;7).</title></caption><graphic xlink:href="pone.0018737.g002"/></fig><table-wrap id="pone-0018737-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018737.t003</object-id><label>Table 3</label><caption><title>Muscle sympathetic nerve activity (burst frequency, burst incidence
and area under the burst) measured on both study days at rest, during
deep breathing (6 breaths per minute), at the end of the maximum
voluntary inspiratory breath hold maneuver (end apnea) and during late
phase II of the Valsalva maneuver.</title></caption><alternatives><graphic id="pone-0018737-t003-3" xlink:href="pone.0018737.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">parameter</td><td align="left" rowspan="1" colspan="1">clean air</td><td align="left" rowspan="1" colspan="1">ozone</td><td align="left" rowspan="1" colspan="1">difference</td><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>baseline</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/min)</td><td align="left" rowspan="1" colspan="1">23&#x000b1;2</td><td align="left" rowspan="1" colspan="1">23&#x000b1;2</td><td align="left" rowspan="1" colspan="1">&#x02212;0.68</td><td align="left" rowspan="1" colspan="1">0.7161</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/100 beats)</td><td align="left" rowspan="1" colspan="1">42&#x000b1;5</td><td align="left" rowspan="1" colspan="1">39&#x000b1;5</td><td align="left" rowspan="1" colspan="1">&#x02212;2.69</td><td align="left" rowspan="1" colspan="1">0.4886</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (area/min)</td><td align="left" rowspan="1" colspan="1">1.23&#x000b1;0.30</td><td align="left" rowspan="1" colspan="1">1.04&#x000b1;0.15</td><td align="left" rowspan="1" colspan="1">&#x02212;0.14</td><td align="left" rowspan="1" colspan="1">0.5861</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>deep breathing</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/min)</td><td align="left" rowspan="1" colspan="1">20&#x000b1;2</td><td align="left" rowspan="1" colspan="1">22&#x000b1;2</td><td align="left" rowspan="1" colspan="1">1.45</td><td align="left" rowspan="1" colspan="1">0.4119</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/100 beats)</td><td align="left" rowspan="1" colspan="1">33&#x000b1;4</td><td align="left" rowspan="1" colspan="1">35&#x000b1;4</td><td align="left" rowspan="1" colspan="1">1.84</td><td align="left" rowspan="1" colspan="1">0.5322</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (area/min)</td><td align="left" rowspan="1" colspan="1">1.20&#x000b1;0.28</td><td align="left" rowspan="1" colspan="1">1.16&#x000b1;0.19</td><td align="left" rowspan="1" colspan="1">&#x02212;0.04</td><td align="left" rowspan="1" colspan="1">0.8802</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>end apnea</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/min)</td><td align="left" rowspan="1" colspan="1">44&#x000b1;4</td><td align="left" rowspan="1" colspan="1">48&#x000b1;4</td><td align="left" rowspan="1" colspan="1">5.94</td><td align="left" rowspan="1" colspan="1">0.1614</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/100 beats)</td><td align="left" rowspan="1" colspan="1">68&#x000b1;5</td><td align="left" rowspan="1" colspan="1">71&#x000b1;4</td><td align="left" rowspan="1" colspan="1">6.16</td><td align="left" rowspan="1" colspan="1">0.3127</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (area/min)</td><td align="left" rowspan="1" colspan="1">3.79&#x000b1;0.45</td><td align="left" rowspan="1" colspan="1">5.05&#x000b1;0.75</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">0.0862</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>Valsalva late phase
II</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/min)</td><td align="left" rowspan="1" colspan="1">64&#x000b1;5</td><td align="left" rowspan="1" colspan="1">57&#x000b1;6</td><td align="left" rowspan="1" colspan="1">&#x02212;10.19</td><td align="left" rowspan="1" colspan="1">0.1496</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (bursts/100 beats)</td><td align="left" rowspan="1" colspan="1">75&#x000b1;4</td><td align="left" rowspan="1" colspan="1">68&#x000b1;6</td><td align="left" rowspan="1" colspan="1">&#x02212;10.28</td><td align="left" rowspan="1" colspan="1">0.1293</td></tr><tr><td align="left" rowspan="1" colspan="1">MSNA (area/min)</td><td align="left" rowspan="1" colspan="1">3.94&#x000b1;0.36</td><td align="left" rowspan="1" colspan="1">4.83&#x000b1;0.96</td><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">0.4950</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>mean values &#x000b1; SEM (n&#x0200a;=&#x0200a;11), MSNA
&#x0200a;=&#x0200a; muscle sympathetic nerve activity.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d"><title>Heart rate variability and baroreflex sensitivity</title><p>
<xref ref-type="table" rid="pone-0018737-t004">Table 4</xref> presents the mean
values of heart rate variability, blood pressure variability, and baroreflex
sensitivity measured on both study days at rest and during deep breathing. All
calculated parameters were similar on both study days. No significant estimated
treatment effect adjusted for period was detected.</p><table-wrap id="pone-0018737-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018737.t004</object-id><label>Table 4</label><caption><title>Heart rate variability (HRV), blood pressure variability (BPV) and
baroreflex sensitivity (BRS) data measured on both study days at rest
and during deep breathing.</title></caption><alternatives><graphic id="pone-0018737-t004-4" xlink:href="pone.0018737.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">parameter</td><td align="left" rowspan="1" colspan="1">clean air</td><td align="left" rowspan="1" colspan="1">ozone</td><td align="left" rowspan="1" colspan="1">difference</td><td align="left" rowspan="1" colspan="1">p-value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>baseline</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>HRV and BPV</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TP (ms<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">2722&#x000b1;424</td><td align="left" rowspan="1" colspan="1">3433&#x000b1;688</td><td align="left" rowspan="1" colspan="1">874</td><td align="left" rowspan="1" colspan="1">0.2212</td></tr><tr><td align="left" rowspan="1" colspan="1">LF (ms<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">1099&#x000b1;241</td><td align="left" rowspan="1" colspan="1">1363&#x000b1;346</td><td align="left" rowspan="1" colspan="1">333</td><td align="left" rowspan="1" colspan="1">0.3132</td></tr><tr><td align="left" rowspan="1" colspan="1">HF (ms<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">540&#x000b1;80</td><td align="left" rowspan="1" colspan="1">906&#x000b1;287</td><td align="left" rowspan="1" colspan="1">398</td><td align="left" rowspan="1" colspan="1">0.0925</td></tr><tr><td align="left" rowspan="1" colspan="1">LF/HF</td><td align="left" rowspan="1" colspan="1">2.15&#x000b1;0.34</td><td align="left" rowspan="1" colspan="1">2.05&#x000b1;0.43</td><td align="left" rowspan="1" colspan="1">&#x02212;0.03</td><td align="left" rowspan="1" colspan="1">0.9343</td></tr><tr><td align="left" rowspan="1" colspan="1">LF-SBP (mmHg<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">8&#x000b1;1</td><td align="left" rowspan="1" colspan="1">9&#x000b1;2</td><td align="left" rowspan="1" colspan="1">1.24</td><td align="left" rowspan="1" colspan="1">0.4831</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>BRS (ms/mmHg)</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">BRSup</td><td align="left" rowspan="1" colspan="1">22&#x000b1;2</td><td align="left" rowspan="1" colspan="1">26&#x000b1;3</td><td align="left" rowspan="1" colspan="1">3.89</td><td align="left" rowspan="1" colspan="1">0.1911</td></tr><tr><td align="left" rowspan="1" colspan="1">BRSdown</td><td align="left" rowspan="1" colspan="1">21&#x000b1;3</td><td align="left" rowspan="1" colspan="1">23&#x000b1;3</td><td align="left" rowspan="1" colspan="1">1.91</td><td align="left" rowspan="1" colspan="1">0.5779</td></tr><tr><td align="left" rowspan="1" colspan="1">BRSLF</td><td align="left" rowspan="1" colspan="1">13&#x000b1;2</td><td align="left" rowspan="1" colspan="1">13&#x000b1;2</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="1" colspan="1">0.9306</td></tr><tr><td align="left" rowspan="1" colspan="1">BRSHF</td><td align="left" rowspan="1" colspan="1">27&#x000b1;3</td><td align="left" rowspan="1" colspan="1">30&#x000b1;4</td><td align="left" rowspan="1" colspan="1">3.25</td><td align="left" rowspan="1" colspan="1">0.4400</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>deep breathing</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>HRV and BPV</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TP (ms<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">11254&#x000b1;2101</td><td align="left" rowspan="1" colspan="1">12692&#x000b1;2541</td><td align="left" rowspan="1" colspan="1">1658</td><td align="left" rowspan="1" colspan="1">0.2840</td></tr><tr><td align="left" rowspan="1" colspan="1">LF (ms<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">8815&#x000b1;1653</td><td align="left" rowspan="1" colspan="1">10652&#x000b1;2188</td><td align="left" rowspan="1" colspan="1">2035</td><td align="left" rowspan="1" colspan="1">0.1720</td></tr><tr><td align="left" rowspan="1" colspan="1">LF-SBP (mmHg<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">21&#x000b1;3</td><td align="left" rowspan="1" colspan="1">25&#x000b1;5</td><td align="left" rowspan="1" colspan="1">4.51</td><td align="left" rowspan="1" colspan="1">0.2051</td></tr><tr><td align="left" rowspan="1" colspan="1">
<bold><italic>BRS (ms/mmHg)</italic></bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">BRSup</td><td align="left" rowspan="1" colspan="1">35&#x000b1;3</td><td align="left" rowspan="1" colspan="1">39&#x000b1;4</td><td align="left" rowspan="1" colspan="1">3.88</td><td align="left" rowspan="1" colspan="1">0.3087</td></tr><tr><td align="left" rowspan="1" colspan="1">BRSdown</td><td align="left" rowspan="1" colspan="1">21&#x000b1;2</td><td align="left" rowspan="1" colspan="1">19&#x000b1;2</td><td align="left" rowspan="1" colspan="1">&#x02212;3.19</td><td align="left" rowspan="1" colspan="1">0.1657</td></tr><tr><td align="left" rowspan="1" colspan="1">BRSLF</td><td align="left" rowspan="1" colspan="1">16&#x000b1;1</td><td align="left" rowspan="1" colspan="1">16&#x000b1;2</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.8649</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label/><p>mean values &#x000b1; SEM, TP&#x0200a;=&#x0200a; total power, LF
&#x0200a;=&#x0200a; low frequency, HF &#x0200a;=&#x0200a;
high frequency, LF/HF &#x0200a;=&#x0200a; LF to HF ratio,
LF-SBP &#x0200a;=&#x0200a; Low frequency power of systolic
blood pressure variability, BRSup &#x0200a;=&#x0200a;
baroreflex sensitivity calculated by the sequence technique for
increasing blood pressure, BRSdown &#x0200a;=&#x0200a;
baroreflex sensitivity calculated by the sequence technique for
decreasing blood pressure, BRSLF&#x0200a;=&#x0200a; baroreflex
sensitivity calculated by cross spectral analysis in the low
frequency band, BRSHF&#x0200a;=&#x0200a; baroreflex sensitivity
calculated by cross spectral analysis in the high frequency
band.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>The main finding of our study is that neutrophilic airway inflammation induced by
acute ozone exposure was not accompanied by changes in muscle sympathetic nerve
activity in healthy younger subjects. We combined the microneurography technique
with hemodynamic measurements, plasma catecholamine determination, cardiovascular
autonomic function testing, and heart rate as well as blood pressure variability
analysis, which provides more comprehensive insight in autonomic regulation than
either method alone. None of these measurements changed with ozone.</p><p>Ozone exposure is an established model to induce neutrophilic airway inflammation.
The increase in sputum neutrophil counts observed after ozone challenge in our study
is comparable with earlier results.<xref rid="pone.0018737-Holz1" ref-type="bibr">[15]</xref>, <xref rid="pone.0018737-Holz4" ref-type="bibr">[24]</xref> Thus, 250 ppb ozone exposure over three hours in
combination with intermittent exercise leads to consistent increases in neutrophilic
airway inflammation. We assessed airway inflammation six hours after the start of
ozone exposure. Given recent recommendations not to perform more than one sputum
induction within 48 hours, we did not obtain additional samples at a later time
point.<xref rid="pone.0018737-Djukanovic1" ref-type="bibr">[25]</xref>
However, other studies applying similar methodology showed that neutrophilic airway
inflammation persists for at least 24 hours.<xref rid="pone.0018737-Holz2" ref-type="bibr">[18]</xref>, <xref rid="pone.0018737-Mudway1" ref-type="bibr">[26]</xref> In contrast, blood neutrophil
counts rapidly normalize after ozone exposure. Thus, our study allowed to study
influences of local inflammation in the lung without a major systemic inflammatory
response. The issue is important because systemic inflammation could mask
sympathetic activation induced by airway inflammation.<xref rid="pone.0018737-Sayk1" ref-type="bibr">[27]</xref> For ethical reasons we did not
obtain airway biopsies for histological analysis. Therefore, we do not have direct
evidence that increased neutrophil counts in sputum are associated with inflammation
of deeper airway wall portions. However, in previous studies, bronchial biopsies
taken 6 hours<xref rid="pone.0018737-Stenfors1" ref-type="bibr">[28]</xref>, <xref rid="pone.0018737-Krishna1" ref-type="bibr">[29]</xref> or 18 hours <xref rid="pone.0018737-Balmes1" ref-type="bibr">[30]</xref>, <xref rid="pone.0018737-Aris1" ref-type="bibr">[31]</xref> after an acute ozone exposure in
healthy subjects showed increased percentage of neutrophils and total protein
concentration in the bronchial fraction. The observation is consistent with acute
inflammatory cell influx across airway walls. In one study, inflammatory markers in
biopsies did not change with ozone exposure.<xref rid="pone.0018737-Krishna1" ref-type="bibr">[29]</xref> However, epithelial shedding
and substance P release from subepithelial sensory nerves was demonstrated
suggesting that mucosal nerve endings are affected by ozone exposure.<xref rid="pone.0018737-Krishna2" ref-type="bibr">[32]</xref> Furthermore,
experiments in anesthetized and artificially ventilated dogs showed ozone responsive
bronchial C fibers and rapidly adapting receptors <xref rid="pone.0018737-Coleridge1" ref-type="bibr">[33]</xref>. Chest discomfort, which
commonly occurs with deep ozone inhalation, suggest a similar mechanism in human
beings. Therefore, we suggest that the design of our study is suitable to assess
acute influences of superficial airway inflammation on cardiovascular autonomic
control.</p><p>In contrast to many other cardiovascular autonomic measurements, resting MSNA
exhibits surprisingly little intraindividual variability in healthy subjects.<xref rid="pone.0018737-Fagius1" ref-type="bibr">[34]</xref> The technique
has been proven useful studying interactions between respiratory tract and the
cardiovascular system. For example, sympathetic vasomotor tone has been shown to be
tightly regulated by chemoreflex mechanisms.<xref rid="pone.0018737-Somers1" ref-type="bibr">[35]</xref> Furthermore, MSNA is
substantially increased in patients with obstructive sleep apnea <xref rid="pone.0018737-Somers2" ref-type="bibr">[36]</xref>, <xref rid="pone.0018737-Grassi1" ref-type="bibr">[37]</xref> and in patients
with chronic obstructive pulmonary disease<xref rid="pone.0018737-Heindl1" ref-type="bibr">[38]</xref>. Sympathetic activity increases
profoundly during prolonged breath-holding in some cases about tenfold above
baseline.<xref rid="pone.0018737-Heusser1" ref-type="bibr">[39]</xref>
Finally, using the microneurography technique, active smoking and passive smoking
were shown to raise sympathetic activity.<xref rid="pone.0018737-Hausberg1" ref-type="bibr">[40]</xref>, <xref rid="pone.0018737-Narkiewicz1" ref-type="bibr">[41]</xref>
</p><p>Given the excellent reproducibility of the microneurography technique, we are
confident that our study excludes a major change in muscle sympathetic nerve
activity elicited by ozone-induced neutrophilic airway inflammation in young healthy
subjects. In an earlier study, sympathetic vasomotor tone was 34 bursts/min in
control subjects and 61 bursts/min in patients with severe chronic obstructive
pulmonary disease.<xref rid="pone.0018737-Heindl1" ref-type="bibr">[38]</xref> Our study was powered to detect 5 bursts/min differences
in sympathetic vasomotor tone. Sympathetic reflexes regulating the cardiovascular
system often interact with each other as exemplified by baroreflex/chemoreflex
interactions.<xref rid="pone.0018737-Somers3" ref-type="bibr">[42]</xref> Possibly, sympathetic activation through another reflex
pathway could be modulated by neutrophilic airway inflammation. In the event, ozone
exposure did not change the sympathetic response to respiratory stimuli like deep
breathing, maximum endinspiratory apnea, or the Valsalva-Maneuver. Thus, our study
challenges the idea that neutrophilic airway inflammation is sufficient to drive an
increase in muscle sympathetic nerve activity in the absence of abnormalities in
blood gases or pulmonary hemodynamics. Provided that the acute stimulus was
sufficiently strong and properly targeted, our study suggests that airway
inflammation does not elicit a major change in muscle sympathetic nerve activity.
However, we cannot exclude that more chronic changes in airway inflammation
contribute to sympathetic activation in chronic obstructive lung disease or in
asthma. As our subjects were healthy, we cannot exclude the possibility that ozone
exposure produces or exacerbates sympathetic activation in COPD or asthmatic
patients.</p><p>Sympathetic nerve activity during apnea quantified as area under the burst tended to
be increased with ozone exposure. The observation might suggest that airway
inflammation exacerbates sympathetic activation when an additional stimulus is
present.</p><p>Our observations on experimental ozone exposure are relevant for environmental
health, which largely relies on epidemiological observations. Autonomic nervous
system imbalance with increased sympathetic and decreased parasympathetic
cardiovascular control may be mechanistic link between air pollution and excess
cardiovascular mortality.<xref rid="pone.0018737-World1" ref-type="bibr">[1]</xref> The rapid onset of cardiovascular events after exposure
supports this idea.<xref rid="pone.0018737-Brook1" ref-type="bibr">[43]</xref> Indeed, in an epidemiological study in 2681 men and
women, resting heart rate increased slightly during an air pollution episode.<xref rid="pone.0018737-Peters1" ref-type="bibr">[44]</xref> Fine particle
exposure during the previous day reduced heart rate variability in another
study.<xref rid="pone.0018737-LuttmannGibson1" ref-type="bibr">[11]</xref> Reduced heart rate variability was also observed with
increased exposure to ozone.<xref rid="pone.0018737-Park2" ref-type="bibr">[45]</xref> However, the relationship may be attenuated after
statistical adjustment for fine particle exposure.<xref rid="pone.0018737-Holguin1" ref-type="bibr">[46]</xref> Finally, experimental exposure
to an ozone/fine particle mixture raised diastolic blood pressure.<xref rid="pone.0018737-Urch1" ref-type="bibr">[47]</xref> Changes in
autonomic regulation with exposure to air pollution may result from direct effects
on rapidly adapting receptors or C-fibers in the lung or oxidative stress and
release of inflammatory cytokines in the lung or elsewhere in the body.<xref rid="pone.0018737-Brook1" ref-type="bibr">[43]</xref> Our study
suggests that persistent airway inflammation induced by acute exposure to ozone
without additional pollutants is unlikely to induce an acute change in
cardiovascular autonomic regulation. The idea is supported by the observation that
environmental ozone exposure is associated with increased risk for death from
respiratory causes whereas cardiovascular risk is related to fine particle
exposure.<xref rid="pone.0018737-Jerrett1" ref-type="bibr">[3]</xref>
</p><sec id="s4a"><title>Conclusion</title><p>We applied ozone exposure as a model for neutrophilic airway inflammation, which
is a common feature observed in chronic obstructive lung disease. Given the
design of our study, we were only able to test the effect of an acute airway
inflammation, therefore we cannot exclude that chronic airway inflammation has
the potential to affect autonomic cardiovascular regulation. Nevertheless, our
study suggests that acute airway inflammation is not sufficient to drive
sympathetic activation, an observation that is also relevant for environmental
health. Over the last decades, pulmonary medicine and cardiovascular medicine
developed exciting new methodologies. Our study underscores the need to join
forces for patient oriented research projects on mechanisms mediating
cardiovascular disease in pulmonary patients.</p></sec></sec></body><back><ack><p>We would like to express our gratefulness to the study nurses of the department of
clinical airway research for patient recruitment and management. The authors thank
Rudolf J&#x000f6;rres for advice with ozone challenge and induced sputum
methodology.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported by the Deutsche Forschungsgemeinschaft, Project BI
1403/1-1. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0018737-World1"><label>1</label><element-citation publication-type="book">
<collab>World Health Organisation World Health Report: reducing risks and
promoting healthy life</collab>
<year>2002</year>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>World Health Organisation</publisher-name>
</element-citation></ref><ref id="pone.0018737-Pope1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pope</surname><given-names>CA</given-names></name><name><surname>III</surname></name><name><surname>Burnett</surname><given-names>RT</given-names></name><name><surname>Thurston</surname><given-names>GD</given-names></name><name><surname>Thun</surname><given-names>MJ</given-names></name><name><surname>Calle</surname><given-names>EE</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Cardiovascular mortality and long-term exposure to particulate
air pollution: epidemiological evidence of general pathophysiological
pathways of disease.</article-title>
<source>Circulation</source>
<volume>109</volume>
<issue>1</issue>
<fpage>71</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">14676145</pub-id></element-citation></ref><ref id="pone.0018737-Jerrett1"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jerrett</surname><given-names>M</given-names></name><name><surname>Burnett</surname><given-names>RT</given-names></name><name><surname>Pope</surname><given-names>CA</given-names></name><name><surname>III</surname></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Thurston</surname><given-names>G</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Long-term ozone exposure and mortality.</article-title>
<source>N Engl J Med</source>
<volume>360</volume>
<issue>11</issue>
<fpage>1085</fpage>
<lpage>1095</lpage>
<pub-id pub-id-type="pmid">19279340</pub-id></element-citation></ref><ref id="pone.0018737-Kim1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>CS</given-names></name><name><surname>Alexis</surname><given-names>NE</given-names></name><name><surname>Rappold</surname><given-names>AG</given-names></name><name><surname>Kehrl</surname><given-names>H</given-names></name><name><surname>Hazucha</surname><given-names>MJ</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Lung Function and Inflammatory Responses in Healthy Young Adults
Exposed to 0.06 ppm Ozone for 6.6 Hours.</article-title>
<source>Am J Respir Crit Care Med</source>
<comment>[Epub ahead of print]</comment>
</element-citation></ref><ref id="pone.0018737-Liu1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Poon</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Frescura</surname><given-names>AM</given-names></name><name><surname>Montuschi</surname><given-names>P</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Acute effects of air pollution on pulmonary function, airway
inflammation, and oxidative stress in asthmatic children.</article-title>
<source>Environ Health Perspect</source>
<volume>117</volume>
<issue>4</issue>
<fpage>668</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">19440509</pub-id></element-citation></ref><ref id="pone.0018737-Thayer1"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thayer</surname><given-names>JF</given-names></name><name><surname>Yamamoto</surname><given-names>SS</given-names></name><name><surname>Brosschot</surname><given-names>JF</given-names></name></person-group>
<year>2010</year>
<article-title>The relationship of autonomic imbalance, heart rate variability
and cardiovascular disease risk factors.</article-title>
<source>Int J Cardiol</source>
<volume>141</volume>
<issue>2</issue>
<fpage>122</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="pmid">19910061</pub-id></element-citation></ref><ref id="pone.0018737-Chuang1"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chuang</surname><given-names>KJ</given-names></name><name><surname>Chan</surname><given-names>CC</given-names></name><name><surname>Su</surname><given-names>TC</given-names></name><name><surname>Lee</surname><given-names>CT</given-names></name><name><surname>Tang</surname><given-names>CS</given-names></name></person-group>
<year>2007</year>
<article-title>The effect of urban air pollution on inflammation, oxidative
stress, coagulation, and autonomic dysfunction in young
adults.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>176</volume>
<issue>4</issue>
<fpage>370</fpage>
<lpage>376</lpage>
<pub-id pub-id-type="pmid">17463411</pub-id></element-citation></ref><ref id="pone.0018737-Park1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O'Neill</surname><given-names>MS</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group>
<year>2005</year>
<article-title>Effects of air pollution on heart rate variability: the VA
normative aging study.</article-title>
<source>Environ Health Perspect</source>
<volume>113</volume>
<issue>3</issue>
<fpage>304</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="pmid">15743719</pub-id></element-citation></ref><ref id="pone.0018737-Gold1"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gold</surname><given-names>DR</given-names></name><name><surname>Litonjua</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Lovett</surname><given-names>E</given-names></name><name><surname>Larson</surname><given-names>A</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Ambient pollution and heart rate variability.</article-title>
<source>Circulation</source>
<volume>101</volume>
<issue>11</issue>
<fpage>1267</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="pmid">10725286</pub-id></element-citation></ref><ref id="pone.0018737-Power1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Power</surname><given-names>KL</given-names></name><name><surname>Balmes</surname><given-names>J</given-names></name><name><surname>Solomon</surname><given-names>C</given-names></name></person-group>
<year>2008</year>
<article-title>Controlled exposure to combined particles and ozone decreases
heart rate variability.</article-title>
<source>J Occup Environ Med</source>
<volume>50</volume>
<issue>11</issue>
<fpage>1253</fpage>
<lpage>1260</lpage>
<pub-id pub-id-type="pmid">19001951</pub-id></element-citation></ref><ref id="pone.0018737-LuttmannGibson1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luttmann-Gibson</surname><given-names>H</given-names></name><name><surname>Suh</surname><given-names>HH</given-names></name><name><surname>Coull</surname><given-names>BA</given-names></name><name><surname>Dockery</surname><given-names>DW</given-names></name><name><surname>Sarnat</surname><given-names>SE</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Short-term effects of air pollution on heart rate variability in
senior adults in Steubenville, Ohio.</article-title>
<source>J Occup Environ Med</source>
<volume>48</volume>
<issue>8</issue>
<fpage>780</fpage>
<lpage>788</lpage>
<pub-id pub-id-type="pmid">16902370</pub-id></element-citation></ref><ref id="pone.0018737-Fakhri1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fakhri</surname><given-names>AA</given-names></name><name><surname>Ilic</surname><given-names>LM</given-names></name><name><surname>Wellenius</surname><given-names>GA</given-names></name><name><surname>Urch</surname><given-names>B</given-names></name><name><surname>Silverman</surname><given-names>F</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Autonomic effects of controlled fine particulate exposure in
young healthy adults: effect modification by ozone.</article-title>
<source>Environ Health Perspect</source>
<volume>117</volume>
<issue>8</issue>
<fpage>1287</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="pmid">19672410</pub-id></element-citation></ref><ref id="pone.0018737-Ye1"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ye</surname><given-names>S</given-names></name><name><surname>Gamburd</surname><given-names>M</given-names></name><name><surname>Mozayeni</surname><given-names>P</given-names></name><name><surname>Koss</surname><given-names>M</given-names></name><name><surname>Campese</surname><given-names>VM</given-names></name></person-group>
<year>1998</year>
<article-title>A limited renal injury may cause a permanent form of neurogenic
hypertension.</article-title>
<source>Am J Hypertens</source>
<issue>6 Pt 1</issue>
<fpage>723</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">9657632</pub-id></element-citation></ref><ref id="pone.0018737-Ordway1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ordway</surname><given-names>GA</given-names></name><name><surname>Boheler</surname><given-names>KR</given-names></name><name><surname>Longhurst</surname><given-names>JC</given-names></name></person-group>
<year>1988</year>
<article-title>Stimulating intestinal afferents reflexly activates
cardiovascular system in cats.</article-title>
<source>Am J Physiol</source>
<volume>254</volume>
<issue>2 Pt 2</issue>
<fpage>H354</fpage>
<lpage>H360</lpage>
<pub-id pub-id-type="pmid">2894173</pub-id></element-citation></ref><ref id="pone.0018737-Holz1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holz</surname><given-names>O</given-names></name><name><surname>Tal-Singer</surname><given-names>R</given-names></name><name><surname>Kanniess</surname><given-names>F</given-names></name><name><surname>Simpson</surname><given-names>KJ</given-names></name><name><surname>Gibson</surname><given-names>A</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Validation of the human ozone challenge model as a tool for
assessing anti-inflammatory drugs in early development.</article-title>
<source>J Clin Pharmacol</source>
<volume>45</volume>
<issue>5</issue>
<fpage>498</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="pmid">15831772</pub-id></element-citation></ref><ref id="pone.0018737-Bernardi1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>L</given-names></name><name><surname>Casucci</surname><given-names>G</given-names></name><name><surname>Haider</surname><given-names>T</given-names></name><name><surname>Brandstatter</surname><given-names>E</given-names></name><name><surname>Pocecco</surname><given-names>E</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Autonomic and cerebrovascular abnormalities in mild COPD are
worsened by chronic smoking.</article-title>
<source>Eur Respir J</source>
<volume>32</volume>
<issue>6</issue>
<fpage>1458</fpage>
<lpage>1465</lpage>
<pub-id pub-id-type="pmid">18799508</pub-id></element-citation></ref><ref id="pone.0018737-Kumar1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Verma</surname><given-names>NS</given-names></name><name><surname>Tiwari</surname><given-names>S</given-names></name><name><surname>Pandey</surname><given-names>US</given-names></name></person-group>
<year>2005</year>
<article-title>Sympathetic hyperactivity in patients of bronchial
asthma.</article-title>
<source>Indian J Physiol Pharmacol</source>
<volume>49</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">15881864</pub-id></element-citation></ref><ref id="pone.0018737-Holz2"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holz</surname><given-names>O</given-names></name><name><surname>Jorres</surname><given-names>RA</given-names></name><name><surname>Timm</surname><given-names>P</given-names></name><name><surname>Mucke</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>K</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>Ozone-induced airway inflammatory changes differ between
individuals and are reproducible.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>159</volume>
<issue>3</issue>
<fpage>776</fpage>
<lpage>784</lpage>
<pub-id pub-id-type="pmid">10051250</pub-id></element-citation></ref><ref id="pone.0018737-Holz3"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holz</surname><given-names>O</given-names></name><name><surname>Richter</surname><given-names>K</given-names></name><name><surname>Jorres</surname><given-names>RA</given-names></name><name><surname>Speckin</surname><given-names>P</given-names></name><name><surname>Mucke</surname><given-names>M</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Changes in sputum composition between two inductions performed on
consecutive days.</article-title>
<source>Thorax</source>
<volume>53</volume>
<issue>2</issue>
<fpage>83</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">9624289</pub-id></element-citation></ref><ref id="pone.0018737-Tank1"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tank</surname><given-names>J</given-names></name><name><surname>Schroeder</surname><given-names>C</given-names></name><name><surname>Diedrich</surname><given-names>A</given-names></name><name><surname>Szczech</surname><given-names>E</given-names></name><name><surname>Haertter</surname><given-names>S</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Selective impairment in sympathetic vasomotor control with
norepinephrine transporter inhibition.</article-title>
<source>Circulation</source>
<volume>107</volume>
<issue>23</issue>
<fpage>2949</fpage>
<lpage>2954</lpage>
<pub-id pub-id-type="pmid">12796139</pub-id></element-citation></ref><ref id="pone.0018737-Hirsch1"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>JA</given-names></name><name><surname>Bishop</surname><given-names>B</given-names></name></person-group>
<year>1981</year>
<article-title>Respiratory sinus arrhythmia in humans: how breathing pattern
modulates heart rate.</article-title>
<source>Am J Physiol</source>
<volume>241</volume>
<issue>4</issue>
<fpage>H620</fpage>
<lpage>H629</lpage>
<pub-id pub-id-type="pmid">7315987</pub-id></element-citation></ref><ref id="pone.0018737-Heart1"><label>22</label><element-citation publication-type="journal">
<article-title>Heart rate variability. Standards of measurement, physiological
interpretation, and clinical use. Task Force of the European Society of
Cardiology and the North American Society of Pacing and
Electrophysiology.</article-title>
<source>Eur Heart J</source>
<volume>17</volume>
<issue>3</issue>
<fpage>354</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="pmid">8737210</pub-id></element-citation></ref><ref id="pone.0018737-Immink1"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Immink</surname><given-names>RV</given-names></name><name><surname>van den Born</surname><given-names>BJ</given-names></name><name><surname>van Montfrans</surname><given-names>GA</given-names></name><name><surname>Koopmans</surname><given-names>RP</given-names></name><name><surname>Karemaker</surname><given-names>JM</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Impaired cerebral autoregulation in patients with malignant
hypertension.</article-title>
<source>Circulation</source>
<volume>110</volume>
<issue>15</issue>
<fpage>2241</fpage>
<lpage>2245</lpage>
<pub-id pub-id-type="pmid">15466625</pub-id></element-citation></ref><ref id="pone.0018737-Holz4"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holz</surname><given-names>O</given-names></name><name><surname>Mucke</surname><given-names>M</given-names></name><name><surname>Paasch</surname><given-names>K</given-names></name><name><surname>Bohme</surname><given-names>S</given-names></name><name><surname>Timm</surname><given-names>P</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Repeated ozone exposures enhance bronchial allergen responses in
subjects with rhinitis or asthma.</article-title>
<source>Clin Exp Allergy</source>
<volume>32</volume>
<issue>5</issue>
<fpage>681</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="pmid">11994090</pub-id></element-citation></ref><ref id="pone.0018737-Djukanovic1"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Djukanovic</surname><given-names>R</given-names></name><name><surname>Sterk</surname><given-names>PJ</given-names></name><name><surname>Fahy</surname><given-names>JV</given-names></name><name><surname>Hargreave</surname><given-names>FE</given-names></name></person-group>
<year>2002</year>
<article-title>Standardised methodology of sputum induction and
processing.</article-title>
<source>Eur Respir J Suppl</source>
<volume> 37</volume>
<fpage>1s</fpage>
<lpage>2s</lpage>
<pub-id pub-id-type="pmid">12361359</pub-id></element-citation></ref><ref id="pone.0018737-Mudway1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mudway</surname><given-names>IS</given-names></name><name><surname>Kelly</surname><given-names>FJ</given-names></name></person-group>
<year>2004</year>
<article-title>An investigation of inhaled ozone dose and the magnitude of
airway inflammation in healthy adults.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>169</volume>
<issue>10</issue>
<fpage>1089</fpage>
<lpage>1095</lpage>
<pub-id pub-id-type="pmid">14754762</pub-id></element-citation></ref><ref id="pone.0018737-Sayk1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sayk</surname><given-names>F</given-names></name><name><surname>Vietheer</surname><given-names>A</given-names></name><name><surname>Schaaf</surname><given-names>B</given-names></name><name><surname>Wellhoener</surname><given-names>P</given-names></name><name><surname>Weitz</surname><given-names>G</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Endotoxemia causes central downregulation of sympathetic
vasomotor tone in healthy humans.</article-title>
<source>Am J Physiol Regul Integr Comp Physiol</source>
<volume>295</volume>
<issue>3</issue>
<fpage>R891</fpage>
<lpage>R898</lpage>
<pub-id pub-id-type="pmid">18635446</pub-id></element-citation></ref><ref id="pone.0018737-Stenfors1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stenfors</surname><given-names>N</given-names></name><name><surname>Pourazar</surname><given-names>J</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name><name><surname>Krishna</surname><given-names>MT</given-names></name><name><surname>Mudway</surname><given-names>I</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Effect of ozone on bronchial mucosal inflammation in asthmatic
and healthy subjects.</article-title>
<source>Respir Med</source>
<volume>96</volume>
<issue>5</issue>
<fpage>352</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">12113386</pub-id></element-citation></ref><ref id="pone.0018737-Krishna1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krishna</surname><given-names>MT</given-names></name><name><surname>Madden</surname><given-names>J</given-names></name><name><surname>Teran</surname><given-names>LM</given-names></name><name><surname>Biscione</surname><given-names>GL</given-names></name><name><surname>Lau</surname><given-names>LC</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Effects of 0.2 ppm ozone on biomarkers of inflammation in
bronchoalveolar lavage fluid and bronchial mucosa of healthy
subjects.</article-title>
<source>Eur Respir J</source>
<volume>11</volume>
<issue>6</issue>
<fpage>1294</fpage>
<lpage>1300</lpage>
<pub-id pub-id-type="pmid">9657569</pub-id></element-citation></ref><ref id="pone.0018737-Balmes1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Balmes</surname><given-names>JR</given-names></name><name><surname>Aris</surname><given-names>RM</given-names></name><name><surname>Chen</surname><given-names>LL</given-names></name><name><surname>Scannell</surname><given-names>C</given-names></name><name><surname>Tager</surname><given-names>IB</given-names></name><etal/></person-group>
<year>1997</year>
<article-title>Effects of ozone on normal and potentially sensitive human
subjects. Part I: Airway inflammation and responsiveness to ozone in normal
and asthmatic subjects.</article-title>
<source>Res Rep Health Eff Inst</source>
<issue>78</issue>
<fpage>1</fpage>
<lpage>37</lpage>
</element-citation></ref><ref id="pone.0018737-Aris1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aris</surname><given-names>RM</given-names></name><name><surname>Christian</surname><given-names>D</given-names></name><name><surname>Hearne</surname><given-names>PQ</given-names></name><name><surname>Kerr</surname><given-names>K</given-names></name><name><surname>Finkbeiner</surname><given-names>WE</given-names></name><etal/></person-group>
<year>1993</year>
<article-title>Ozone-induced airway inflammation in human subjects as determined
by airway lavage and biopsy.</article-title>
<source>Am Rev Respir Dis</source>
<volume>148</volume>
<issue>5</issue>
<fpage>1363</fpage>
<lpage>1372</lpage>
<pub-id pub-id-type="pmid">8239177</pub-id></element-citation></ref><ref id="pone.0018737-Krishna2"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krishna</surname><given-names>MT</given-names></name><name><surname>Springall</surname><given-names>D</given-names></name><name><surname>Meng</surname><given-names>QH</given-names></name><name><surname>Withers</surname><given-names>N</given-names></name><name><surname>Macleod</surname><given-names>D</given-names></name><etal/></person-group>
<year>1997</year>
<article-title>Effects of ozone on epithelium and sensory nerves in the
bronchial mucosa of healthy humans.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>156</volume>
<issue>3 Pt 1</issue>
<fpage>943</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="pmid">9310018</pub-id></element-citation></ref><ref id="pone.0018737-Coleridge1"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coleridge</surname><given-names>JC</given-names></name><name><surname>Coleridge</surname><given-names>HM</given-names></name><name><surname>Schelegle</surname><given-names>ES</given-names></name><name><surname>Green</surname><given-names>JF</given-names></name></person-group>
<year>1993</year>
<article-title>Acute inhalation of ozone stimulates bronchial C-fibers and
rapidly adapting receptors in dogs.</article-title>
<source>J Appl Physiol</source>
<volume>74</volume>
<issue>5</issue>
<fpage>2345</fpage>
<lpage>2352</lpage>
<pub-id pub-id-type="pmid">8335566</pub-id></element-citation></ref><ref id="pone.0018737-Fagius1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fagius</surname><given-names>J</given-names></name><name><surname>Wallin</surname><given-names>BG</given-names></name></person-group>
<year>1993</year>
<article-title>Long-term variability and reproducibility of resting human muscle
nerve sympathetic activity at rest, as reassessed after a
decade.</article-title>
<source>Clin Auton Res</source>
<volume>3</volume>
<issue>3</issue>
<fpage>201</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="pmid">8400820</pub-id></element-citation></ref><ref id="pone.0018737-Somers1"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Somers</surname><given-names>VK</given-names></name><name><surname>Mark</surname><given-names>AL</given-names></name><name><surname>Zavala</surname><given-names>DC</given-names></name><name><surname>Abboud</surname><given-names>FM</given-names></name></person-group>
<year>1989</year>
<article-title>Contrasting effects of hypoxia and hypercapnia on ventilation and
sympathetic activity in humans.</article-title>
<source>J Appl Physiol</source>
<volume>67</volume>
<issue>5</issue>
<fpage>2101</fpage>
<lpage>2106</lpage>
<pub-id pub-id-type="pmid">2513316</pub-id></element-citation></ref><ref id="pone.0018737-Somers2"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Somers</surname><given-names>VK</given-names></name><name><surname>Dyken</surname><given-names>ME</given-names></name><name><surname>Clary</surname><given-names>MP</given-names></name><name><surname>Abboud</surname><given-names>FM</given-names></name></person-group>
<year>1995</year>
<article-title>Sympathetic neural mechanisms in obstructive sleep
apnea.</article-title>
<source>J Clin Invest</source>
<volume>96</volume>
<issue>4</issue>
<fpage>1897</fpage>
<lpage>1904</lpage>
<pub-id pub-id-type="pmid">7560081</pub-id></element-citation></ref><ref id="pone.0018737-Grassi1"><label>37</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grassi</surname><given-names>G</given-names></name><name><surname>Facchini</surname><given-names>A</given-names></name><name><surname>Trevano</surname><given-names>FQ</given-names></name><name><surname>Dell'Oro</surname><given-names>R</given-names></name><name><surname>Arenare</surname><given-names>F</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Obstructive sleep apnea-dependent and -independent adrenergic
activation in obesity.</article-title>
<source>Hypertension</source>
<volume>46</volume>
<issue>2</issue>
<fpage>321</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="pmid">15983234</pub-id></element-citation></ref><ref id="pone.0018737-Heindl1"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heindl</surname><given-names>S</given-names></name><name><surname>Lehnert</surname><given-names>M</given-names></name><name><surname>Criee</surname><given-names>CP</given-names></name><name><surname>Hasenfuss</surname><given-names>G</given-names></name><name><surname>Andreas</surname><given-names>S</given-names></name></person-group>
<year>2001</year>
<article-title>Marked sympathetic activation in patients with chronic
respiratory failure.</article-title>
<source>Am J Respir Crit Care Med</source>
<volume>164</volume>
<issue>4</issue>
<fpage>597</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="pmid">11520722</pub-id></element-citation></ref><ref id="pone.0018737-Heusser1"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heusser</surname><given-names>K</given-names></name><name><surname>Dzamonja</surname><given-names>G</given-names></name><name><surname>Tank</surname><given-names>J</given-names></name><name><surname>Palada</surname><given-names>I</given-names></name><name><surname>Valic</surname><given-names>Z</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Cardiovascular regulation during apnea in elite
divers.</article-title>
<source>Hypertension</source>
<volume>53</volume>
<issue>4</issue>
<fpage>719</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="pmid">19255361</pub-id></element-citation></ref><ref id="pone.0018737-Hausberg1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hausberg</surname><given-names>M</given-names></name><name><surname>Mark</surname><given-names>AL</given-names></name><name><surname>Winniford</surname><given-names>MD</given-names></name><name><surname>Brown</surname><given-names>RE</given-names></name><name><surname>Somers</surname><given-names>VK</given-names></name></person-group>
<year>1997</year>
<article-title>Sympathetic and vascular effects of short-term passive smoke
exposure in healthy nonsmokers.</article-title>
<source>Circulation</source>
<volume>96</volume>
<issue>1</issue>
<fpage>282</fpage>
<lpage>287</lpage>
<pub-id pub-id-type="pmid">9236446</pub-id></element-citation></ref><ref id="pone.0018737-Narkiewicz1"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Narkiewicz</surname><given-names>K</given-names></name><name><surname>van de Borne</surname><given-names>PJ</given-names></name><name><surname>Hausberg</surname><given-names>M</given-names></name><name><surname>Cooley</surname><given-names>RL</given-names></name><name><surname>Winniford</surname><given-names>MD</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Cigarette smoking increases sympathetic outflow in
humans.</article-title>
<source>Circulation</source>
<volume>98</volume>
<issue>6</issue>
<fpage>528</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="pmid">9714109</pub-id></element-citation></ref><ref id="pone.0018737-Somers3"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Somers</surname><given-names>VK</given-names></name><name><surname>Mark</surname><given-names>AL</given-names></name><name><surname>Abboud</surname><given-names>FM</given-names></name></person-group>
<year>1991</year>
<article-title>Interaction of baroreceptor and chemoreceptor reflex control of
sympathetic nerve activity in normal humans.</article-title>
<source>J Clin.Invest</source>
<volume>87</volume>
<issue>6</issue>
<fpage>1953</fpage>
<lpage>1957</lpage>
<pub-id pub-id-type="pmid">2040688</pub-id></element-citation></ref><ref id="pone.0018737-Brook1"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brook</surname><given-names>RD</given-names></name></person-group>
<year>2008</year>
<article-title>Cardiovascular effects of air pollution.</article-title>
<source>Clin Sci (Lond)</source>
<volume>115</volume>
<issue>6</issue>
<fpage>175</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">18691154</pub-id></element-citation></ref><ref id="pone.0018737-Peters1"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Perz</surname><given-names>S</given-names></name><name><surname>Doring</surname><given-names>A</given-names></name><name><surname>Stieber</surname><given-names>J</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>Increases in heart rate during an air pollution
episode.</article-title>
<source>Am J Epidemiol</source>
<volume>150</volume>
<issue>10</issue>
<fpage>1094</fpage>
<lpage>1098</lpage>
<pub-id pub-id-type="pmid">10568625</pub-id></element-citation></ref><ref id="pone.0018737-Park2"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O'Neill</surname><given-names>MS</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group>
<year>2005</year>
<article-title>Effects of air pollution on heart rate variability: the VA
normative aging study.</article-title>
<source>Environ Health Perspect</source>
<volume>113</volume>
<issue>3</issue>
<fpage>304</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="pmid">15743719</pub-id></element-citation></ref><ref id="pone.0018737-Holguin1"><label>46</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holguin</surname><given-names>F</given-names></name><name><surname>Tellez-Rojo</surname><given-names>MM</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Cortez</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>JC</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Air pollution and heart rate variability among the elderly in
Mexico City.</article-title>
<source>Epidemiology</source>
<volume>14</volume>
<issue>5</issue>
<fpage>521</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="pmid">14501266</pub-id></element-citation></ref><ref id="pone.0018737-Urch1"><label>47</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urch</surname><given-names>B</given-names></name><name><surname>Silverman</surname><given-names>F</given-names></name><name><surname>Corey</surname><given-names>P</given-names></name><name><surname>Brook</surname><given-names>JR</given-names></name><name><surname>Lukic</surname><given-names>KZ</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Acute blood pressure responses in healthy adults during
controlled air pollution exposures.</article-title>
<source>Environ Health Perspect</source>
<volume>113</volume>
<issue>8</issue>
<fpage>1052</fpage>
<lpage>1055</lpage>
<pub-id pub-id-type="pmid">16079078</pub-id></element-citation></ref></ref-list></back></article>